GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » 3-Year Dividend Growth Rate

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co 3-Year Dividend Growth Rate?

Shenzhenlubris Pharmaceuticals Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

The historical rank and industry rank for Shenzhenlubris Pharmaceuticals Co's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shenzhenlubris Pharmaceuticals Co was 75.50% per year. The lowest was -20.60% per year. And the median was 23.10% per year.

SZSE:002294's 3-Year Dividend Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 11.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

During the past 12 months, Shenzhenlubris Pharmaceuticals Co's average Dividends Per Share Growth Rate was 25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Shenzhenlubris Pharmaceuticals Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Shenzhenlubris Pharmaceuticals Co's Dividend Yield % is 1.83%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shenzhen Salubris Pharmaceuticals Co Ltd is 0.91, which seems too high.

Good Sign:

Shenzhen Salubris Pharmaceuticals Co Ltd stock dividend yield is close to 3-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's 3-Year Dividend Growth Rate

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhenlubris Pharmaceuticals Co's 3-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's 3-Year Dividend Growth Rate falls into.



Shenzhenlubris Pharmaceuticals Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Shenzhenlubris Pharmaceuticals Co  (SZSE:002294) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Shenzhenlubris Pharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.183
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Shenzhenlubris Pharmaceuticals Co was 125.00. The lowest was 0.37. And the median was 0.60.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shenzhen Salubris Pharmaceuticals Co Ltd is 0.91, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Shenzhenlubris Pharmaceuticals Co was 4.60%. The lowest was 0.84%. And the median was 1.70%.

Good Sign:

Shenzhen Salubris Pharmaceuticals Co Ltd stock dividend yield is close to 3-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhenlubris Pharmaceuticals Co 3-Year Dividend Growth Rate Related Terms>


Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Traded in Other Exchanges
N/A
Address
1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.
Executives
Yan Jie Directors, executives
Yang Jian Feng Secretary, Director
Zhao Song Ping Executives
Liu Jun Executives
Li Ai Zhen Supervisors
Chen Ping Executives
Ye Cheng Hai Director
Lu Feng Executives, directors
Chen Qiong Xing Supervisors
Li Ying Hui Supervisors
Pan Ling Man Independent director
Zhang Zhong Xing Executives

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines